Breaking News
In a significant development for the MAHA movement, the House Oversight Committee has announced a formal inquiry into FDA Commissioner's ties to pharmaceutical companies prior to taking office. The inquiry, led by Representatives from both parties, will examine whether conflicts of interest influenced recent drug approval decisions, particularly
Exposés
A senior CDC epidemiologist has come forward with explosive allegations that the agency systematically excluded unfavorable data from key childhood vaccine safety studies, according to documents obtained by MAHA Daily. Dr. [Name Redacted], who worked in the CDC's Immunization Safety Office for 15 years, provided congressional investigators with
Exposés
A comprehensive MAHA Daily investigation reveals that pharmaceutical companies have spent over $4.7 billion on federal lobbying over the past decade, employing more lobbyists than there are members of Congress. Our analysis of OpenSecrets data and lobbying disclosures shows the industry maintains 1,800+ registered lobbyists in Washington—that&
Pharmaceutical & Medical Reforms
The MAHA Commission has formally requested an independent scientific review of the childhood vaccine schedule, which has grown from 24 doses in 1983 to 72 doses today, citing concerns about cumulative safety studies. The request calls for scientists with no pharmaceutical industry ties to examine whether the complete schedule has
Pharmaceutical & Medical Reforms
A bipartisan group of senators has introduced legislation to ban direct-to-consumer pharmaceutical advertising, a practice allowed only in the United States and New Zealand among developed nations. The "Prescription Drug Advertising Reform Act" would prohibit TV, radio, print, and digital advertising of prescription medications directly to consumers. The